Justin M Ko, MD MBA
Dermatologist, Melanoma specialist, Cutaneous oncology specialist, Hair loss specialist, Psoriasis specialist
Dr. Ko spearheads efforts around community outreach, screening and digital health. His passion for early cancer detection improving care delivery drives his efforts and collaborations to leverage advances in machine learning and artifical intellegence to increase the breadth of populations that can be reached. Some of this work is featured in Nature; more details can be found here: http://cs.stanford.edu/people/esteva/nature/. Further, he developed and runs a virtual teledermatology care delivery program at SHC; providing virtual visits for established patients and remote consultations for providers within the Stanford network. He welcomes opportunities to discuss and collaborate in these areas of investigation.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss. He and his team recently completed a seminal study that has help to spur further trials investigating the potential of novel agents in treating alopecia areata: https://insight.jci.org/articles/view/89776 For more information on ongoing clinical trials, please email: email@example.com. Dr. Ko sits on the clinical research advisory board of the National Alopecia Areata Foundation.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Combined Dermatology Residency Training Program where he served as chief resident in his final year. He is board certified in dermatology by the American Board of Dermatology.
- Board Certification: Dermatology, American Board of Dermatology (2012)
- Chief Resident, Harvard Combined Dermatology Residency Training Program (2012)
- Residency: Massachusetts General Hospital (2012) MA
- BA, Harvard University, Magna Cum Laude (2002)
- MD, MBA, Tufts University School of Medicine, Alpha Omega Alpha (2008)
- Co-Chair, Clinic Advisory Council, Stanford Health Care (2018 - Present)
- Director and Chief, Medical Dermatology, Stanford Health Care (2012 - Present)
- Director of Outreach and Teledermatology, Stanford Department of Dermatology (2012 - Present)
- Member, Clinic Advisory Council, Stanford Hospital and Clinics (2015 - Present)
- Physician Lead and Co-Chair, Clinic Performance Team 4, Stanford Hospital and Clinics (2015 - 2018)
- Physician Leader, Safety, Quality and Performance Improvement, Department of Dermatology, Stanford University School of Medicine (2017 - Present)
- Service Medical Director, Stanford Health Care (2018 - Present)
Prospective assessment of computer-aided detection in interpretation of screening mammography
Ko, J. M., Nicholas, M. J., Mendel, J. B., & Slanetz, P. J. (2006). Prospective assessment of computer-aided detection in interpretation of screening mammography. AMERICAN JOURNAL OF ROENTGENOLOGY, 187(6), 1483–1491.
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Ko, J. M., Gottlieb, A. B., & Kerbleski, J. F. (2009). Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. JOURNAL OF DERMATOLOGICAL TREATMENT, 20(2), 100–108.
Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis
Ko, J. M., & QURESHI, A. W. (2010). Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 145(3), 393–406.
A new era: melanoma genetics and therapeutics
Ko, J. M., & Fisher, D. E. (2011). A new era: melanoma genetics and therapeutics. JOURNAL OF PATHOLOGY, 223(2), 241–250.
Pathways to Melanoma
Ko, J. M., Velez, N. F., & Tsao, H. (2010). Pathways to Melanoma. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 29(4), 210–217.
A Randomized, Prospective Trial Evaluating Surgeon Preference in Selection of Absorbable Suture Material
Lu, L. K., Ko, J. M., Lee, J., Krum, D. M., Price, L. L., Finn, D., … Rogers, G. S. (2012). A Randomized, Prospective Trial Evaluating Surgeon Preference in Selection of Absorbable Suture Material. JOURNAL OF DRUGS IN DERMATOLOGY, 11(2), 196–201.
Paying for Enhanced Service Comparing Patients' Experiences in a Concierge and General Medicine Practice
Ko, J. M., Rodriguez, H. P., Fairchild, D. G., Rodday, A. M. C., & Safran, D. G. (2009). Paying for Enhanced Service Comparing Patients' Experiences in a Concierge and General Medicine Practice. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2(2), 95–103.
Randomized Controlled Trial of Cryotherapy With Liquid Nitrogen vs Topical Salicylic Acid vs Wait-and-See for Cutaneous Warts
Ko, J., & Bigby, M. (2012). Randomized Controlled Trial of Cryotherapy With Liquid Nitrogen vs Topical Salicylic Acid vs Wait-and-See for Cutaneous Warts. ARCHIVES OF DERMATOLOGY, 148(7), 840–842.
Validation of a Skin-Lesion Image-Matching Algorithm Based on Computer Vision Technology
Chen, R. H., Snorrason, M., Enger, S. M., Mostafa, E., Ko, J. M., Aoki, V., & Bowling, J. (2016). Validation of a Skin-Lesion Image-Matching Algorithm Based on Computer Vision Technology. TELEMEDICINE AND E-HEALTH, 22(1), 45–50.
Implementation and evaluation of Stanford Health Care direct-care teledermatology program.
Pathipati, A. S., & Ko, J. M. (2016). Implementation and evaluation of Stanford Health Care direct-care teledermatology program. SAGE Open Medicine, 4, 2050312116659089-?
A case and review of congenital leukonychia.
Pathipati, A. S., Ko, J. M., & Yost, J. M. (2016). A case and review of congenital leukonychia. Dermatology Online Journal, 22(10).
Crowdsourcing dermatology: DataDerm, big data analytics, and machine learning technology.
Park, A. J., Ko, J. M., & Swerlick, R. A. (2017). Crowdsourcing dermatology: DataDerm, big data analytics, and machine learning technology. Journal of the American Academy of Dermatology.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.